January 28, 2019 The Center for Biosimilars, Proposed CMS Changes Are the Wrong Way to Save Money and Will Harm Patients and Providers

Tagged

#Biologics Prescribers Collaborative #BPC #Centers for Medicare and Medicaid Services #CMS #Medicare Advantage (MA) Program #Medicare Part B #Medicare Part D #step therapy